The Second Edition contains new questions and is completely updated!
Curbside Consultation in Oculoplastics: 49 Clinical Questions, Second Edition contains new questions and brief, practical, evidence-based answers to the most frequently asked questions that are posed during a “curbside consultation” between surgical colleagues.
Dr. Robert C. Kersten and Dr. Timothy J. McCulley have designed this unique reference in which oculoplastic specialists offer expert advice, preferences, and opinions on tough clinical questions commonly associated with ocuplastics. The unique Q&A format provides quick access to current information related to oculoplastics with the simplicity of a conversation between two colleagues. Images, diagrams, and references are included to enhance the text and to illustrate common clinical dilemmas.
Some of the questions that are answered inside the Second Edition include:
- What lasers do you prefer for facial resurfacing?
- When do you worry that an eyelid growth is malignant?
- What are the general treatment guidelines for graves ophthalmopathy?
- How do I know when to order and MRI or CT?
- What is the best approach to manage trichiasis?
- How do I decide whether to perform an enucleation or an evisceration?
Curbside Consultation in Oculoplastics: 49 Clinical Questions, Second Edition provides information basic enough for residents while also incorporating expert pearls that even high-volume ophthalmologists will appreciate. Residents, fellows, and practicing physicians alike will benefit from the user-friendly, casual format and the expert advice contained within.
About the Editors
Section I Cosmetic Oculofacial Plastic Surgery
Question 1 What Are the Current Thoughts on Blepharoplasty?
Peter S. Levin, MD
Question 2 How Can I Address Midface Descent and Volume Depletion?
Roger A. Dailey, MD, FACS
Question 3 What Is the Current Surgical Approach for Brow Ptosis Repair?
Robert C. Kersten, MD, FACS and John D. McCann, MD, PhD
Question 4 What Are Your Recommendations Regarding Asian Blepharoplasty?
William Chen, MD
Question 5 What Is Your Favorite Filler and Why?
Rona Z. Silkiss, MD, FACS
Question 6 What Lasers Are Available and Which Do You Prefer for Facial Resurfacing?
Wendy W. Lee, MD, MS; Audrey C. Ko, MD; and Marcus J. Ko, MD
Question 7 What Is the Difference Between Laser Resurfacing and Chemical Peels?
Jerry K. Popham, MD, FACS
Question 8 What Alternatives to Botox Are Available and How Do They Compare?
Timothy J. McCulley, MD; W. Jordan Piluek, MD; and Lynda V. McCulley, PharmD
Section II Eyelid
Question 9 When Should I Be Concerned About Systemic Disease in a Patient With Blepharoptosis?
Robert C. Kersten, MD, FACS and Chris Thiagarajah, MD, FACS
Question 10 Is There Ever a Genetic Basis for Acquired Blepharoptosis?
Prem Subramanian, MD, PhD
Question 11 Why Does Age-Related Blepharoptosis Occur?
Timothy J. McCulley, MD and W. Jordan Piluek, MD
Question 12 How Should I Manage Blepharoptosis?
Steven C. Dresner, MD
Question 13 How Do I Manage a Child With Congenital Blepharoptosis?
Maryam Nazemzadeh, MD; William R. Katowitz, MD; and James A. Katowitz, MD
Question 14 How Should I Manage Ectropion?
Daniel J. Townsend, MD
Question 15 How Does Transconjunctival Lower Eyelid Entropion Repair Compare With a Transcutaneous Approach?
Catherine J. Hwang, MD and Payam V. Morgan, MD
Question 16 What Is the Role of Tarsorrhaphy?
Gary L. Aguilar, MD and Robert C. Kersten, MD, FACS
Question 17 What Commercially Available Materials Can Be Used as Tissue Substitutes in Eyelid Reconstruction?
Michael K. Yoon, MD and N. Grace Lee, MD
Question 18 When Do You Worry That an Eyelid Growth Is Malignant?
Robert Alan Goldberg, MD
Question 19 When Should Mohs Surgery Be Employed?
Isaac M. Neuhaus, MD
Question 20 Should Periocular Capillary Hemangiomas Be Treated With Corticosteroids, Beta-Blockers, or Surgery?
Roxana Rivera, MD
Question 21 When Does an Eyelid Lesion Need to Be Biopsied?
Richard Collin, MA, FRCS, FRCOphth, DO and Michèle Beaconsfield, DO, FRCS, FRCOphth, FEBO
Question 22 How Should Lentigo Maligna Be Managed?
Bishr Al Dabagh, MD; Linda C. Chang, MD; Murray Cotter, MD, PhD; and Siegrid S. Yu, MD
Question 23 What Topical Therapy Can I Use to Treat Cutaneous Malignancies?
Heidi M. Hermes, MD, FAAD and Timothy S. Wang, MD
Question 24 What Systemic Medical Therapy Is Available for Treatment of Cutaneous Malignancies?
Bobby S. Korn, MD, PhD and Bradford Lee, MD, MSc
Section III Orbital Disease
Question 25 How Do I Know When to Order MRI or CT?
Karl C. Golnik, MD, MEd
Question 26 What Is IgG4 Immune-Related Inflammation of the Orbit and How Do You Treat It?
Elizabeth A. Atchison, MD and James A. Garrity, MD
Question 27 Can You Tell Me About Orbital Infection Due to Hospital- and Community-Acquired MRSA?
Michael T. Yen, MD
Question 28 What Are the General Treatment Guidelines for Graves’ Ophthalmopathy?
Jonathan W. Kim, MD
Question 29 When Should Corticosteroids Be Used for Thyroid Eye Disease?
Mark J. Lucarelli, MD, FACS
Question 30 Do You Think Radiation Is Ever Indicated for Graves’ Disease?
Vikram D. Durairaj, MD
Question 31 Should Local Chemotherapy Play a Role in the Management of Lacrimal or Other Orbital Malignancy?
Andrea Lora Kossler, MD
Question 32 What Is New in the Management of Orbital Lymphoma?
Timothy J. Sullivan, FRANZCO
Section IV Trauma
Question 33 How Do You Treat Children With Orbital Fractures?
Jennifer A. Sivak-Callcott, MD and John Nguyen, MD
Question 34 What Implant Do You Like Best for Repairing Orbital Fractures?
Marc J. Hirschbein, MD, FACS and Ana Carolina Victoria, MD
Question 35 Can You Tell Me About Stereotactic Image Guidance and How It Is Used in Orbital Surgery?
Roger E. Turbin, MD
Question 36 What Is Traumatic Optic Neuropathy?
Stuart R. Seiff, MD, FACS
Question 37 What Should I Do for an Orbital Hemorrhage?
Michael Kazim, MD and Payal Patel, MD
Question 38 How Should Canalicular Lacerations Be Managed?
Louise A. Mawn, MD, FACS
Section V Lacrimal Drainage System
Question 39 What Is New in the Management of Adult Tearing Patients?
Daniel G. Ezra, MA, MBBS, MMedEd, MD, FRCS, FRCOphth and
Geoffrey E. Rose, BSc, MBBS, MS, DSc, MRCP, FRCS, FRCOphth
Question 40 When Managing Patients With Congenital Nasolacrimal Duct Obstruction, Does Balloon Dacryoplasty Work?
Jonathan Song, MD
Question 41 What Medications Cause Canalicular Obstruction and How Do You Prevent or Manage It?
Bita Esmaeli, MD, FACS
Question 42 Is Anything New in the Management of Patients With Canalicular Obstruction?
Thomas E. Johnson, MD and Sophie Liao, MD
Section VI Miscellaneous
Question 43 What Role Can Endoscopes Play in Oculoplastic Surgery?
Don O. Kikkawa, MD and Jane S. Kim, MD
Question 44 What Are American College of Chest Physicians Recommendations for Management of Antithrombotic Therapy
(Anticoagulation) Perioperatively and Are They Applicable to Oculoplastic Surgery?
Nicholas R. Mahoney, MD
Question 45 How Do I Decide Whether to Perform an Evisceration or Enucleation?
Thomas N. Hwang, MD, PhD
Question 46 How Should I Manage Congenital Anophthalmos/Microphthalmos?
Danny Ng, FRCS, MPH and David T. Tse, MD, FACS
Question 47 What Is the Best Approach for Trichiasis?
David R. Jordan, MD, FACS, FRCSC and Bazil Stoica, MD
Question 48 How Should I Manage My Patients With Bell’s Palsy?
Andrew G. Lee, MD
Question 49 What Is Currently Recommended for the Treatment of Herpes Zoster Involving the Face and Eyelids?
Vivek R. Patel, MD
- Diana V. Do, MD, University of Nebraska College of Medicine, Doody’s Review Service
About the Editors
Timothy J. McCulley, MD is the Vice Chair of Clinical Strategic Planning, Primary Preceptor for an American Society of Oculoplastic and Reconstructive Surgery (ASOPRS) Accredited Fellowship, and Director of the Division of Neuro-ophthalmology at the Wilmer Eye Institute, Johns Hopkins School of Medicine. In 1995, he obtained his medical degree at Washington University School of Medicine in St. Louis. After a combined medical and surgical internship at the University of Hawaii, he completed residency in ophthalmology at Stanford University in 1999. Following 1 year of fellowship training in neuro-ophthalmology at the Bascom Palmer Eye Institute, he completed 2 years of fellowship training in ophthalmic plastic and reconstructive surgery at the Cincinnati Eye Institute in 2003. Dr. McCulley was on faculty at Stanford University, where he served as director of both neuro-ophthalmology and oculoplastic surgery. In 2006, he relocated to the University of California San Francisco, where he served as Director of Oculoplastic Surgery and as the primary preceptor for an (ASOPRS) fellowship. Dr. McCulley joined the Wilmer Eye Institute in 2011 and spent 2 years as director of ophthalmic plastic and reconstructive surgery at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia. He returned to Maryland in 2013. This is the second edition of the second book edited by Dr. McCulley. He has also contributed to more than 20 book chapters and authored more than 75 peer-reviewed manuscripts.